Diagnostic Marketing Association

Diagnostic Testing & Healthcare Industry News Updates

The DxMA wishes to thank the EMMES Group for providing the news updates listed below. For more information on any item, please click on the subject to access a PDF file.

November 2007

  • Rapid Test May Make Transfusion of Platelets Safer
  • Inverness Medical Innovations Agrees to Acquire ParadigmHealth
  • Axis-Shield Launches HbA1c Assay on Abbott AxSYM
  • Beckman Coulter to Acquire Flow Cytometry Instrumentation Business from Dako
  • J & J Realigns Managers, Revamps Units
  • Sorenson Genomics to Bring the First-Ever Retail DNA Test to Market
  • Ventana Enters into Confientiality Agreement with Roche
  • Abaxis Announces CLIA-Waived Comprehensive Metabolic Panel
  • Bio-Rad Introduces Chromogenic Medium in the U.S. for Rapid Screening of MRSA
  • Two Point of Care Tests from Quest Diagnostics Receive FDA 510(k) Clearance
  • October 2007

  • StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
  • Ventana to Help Develop Pathway for Companion Diagnostics
  • Siemens Diagnostics and Sysmex Extend Urinalysis Distribution Agreement
  • Cancer Death Rate in U.S. Falling
  • Siemens Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
  • IL Receives FDA Clearance to Expand the Intended Use for Hemosil D-Dimer HS Assay
  • Abbott Broadens Use of i-STAT with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
  • Dade Behring Receives FDA Clearance for Rapid-Result Gram Positive Microbiology Tests
  • Inverness Agrees to Acquire Panbio Ltd. and Bio-State Healthcare Group
  • Ortho Introduces Improved Sensitivity Troponin I Assay to Help Diagnose Hearth Attack, Heart Damage
  • September 2007

  • Dade Behring/Siemens Deal Unlikely To Raise Major Competition Issues But Phase II Cannot Be Excluded
  • Ventana Medical Systems Acquires Spring BioScience
  • Inverness Agrees to Acquire Matritech
  • National Center for Health Statistics Issues New Summary Report Regarding US Population
  • Ciphergen Changes Company Name to Vermillion to Better Reflect Organization's Mission
  • ParagonDx Prepares Molecular Diagnostics Expansion with Aquisition of Gentris Diagnostics
  • Quest Diagnostics Introduces ClariSure Test for Identifying Chromosome Abnormalities Associated with 85 Developmental Disorders in Children
  • Diagnocure Acquires New High-Value Diagnostic Tests for Breast and Colon Cancer
  • UCLA Researchers Identify Markers that May Predict Diabetes in Still-Healthy People
  • Sniff Test May Signal Disorders' Early Stages
  • July 2007

  • Siemens to Aquire Dade Behring
  • QIAGEN Completes Offer for Digene--Anticipates Prompt Completion of Acquisition
  • Luminex Unveils Next Generation Multiplex System
  • Digene Enters Four-Year HPV Testing Contract with Quest Diagnostics
  • Siemens Announces Enhances Liver Fibrosis Test
  • Experimental Blood Test for Prostate Cancer--Hope for a Better Test than PSA
  • Panacea Pharmaceuticals Launches a Serum-Based Diagnostic Test for Lung Cancer
  • Siems Introduces New ADVIA 1800 Chemistry System
  • Seegene Introduces DNA Test to Simultaneously Detest 18 Different Human Papillomaviruses (HPVs)
  • Severin Schwan Currently CEO of Roche Diagnostics to Become Chief Executive of the Roche Group
  • June 2007

  • Dade Behring Grants Sublicense to Beckman Coulter for the Use of Cardiac Markers
  • Roche's Hostile Bid for Ventana would Boost Its Diagnostic Portfolio
  • Roche Makes Offer to Acquire Ventana for $75 US Dollars Per Share In Cash
  • Qiagen and Digene Announce Merger
  • FDA Approves New Rapid Test to Help Diagnost Viral Meningitis
  • Inverness To Acquire Biosite Via Cash Tender at $92.50 Per Share
  • Axis-Shield Launches Afinion ACR Ratio Test for Diabetic Monitoring
  • Inverness Announces Successful Completion of Tender Offer for Biosite
  • FISH on a Chip Offers Quicker, Less Costly Cancer Diagnosis
  • Colon Cancer Proteins Show Promise for Blood Test
  • May 2007

  • Merck Healthcare Executive, Peter Loscher, Picked to Run Siemens
  • Hologic and CYTYC to Merge Creating a $10 Billion Company Focused on Women's Healthcare
  • LabCorp to be First Commercial Laboratory to Offer FDA Approved, Fully Automated Real-Time HIV Test from Roche Diagnostics
  • Study Reveals PNA FISH Significantly Reduces Mortality Associated with S. Aureus Bloodstream Infections in the ICU
  • HPV Test Market Expected to Boom
  • Inverness to Acquire Biosite Via Cash Tender at $92.50 Per Share
  • UK Researchers Identify Potential Marker for Pre-eclampsia in Pregnant Women
  • Beckman Coulter Launches the UniCel DxI 600, Targeted to Mid-Volume Labs
  • Simple Home Spit Test to Spot Deadly Pre-Eclampsia
  • Ortho-Clinical Diagnostics Issues Voluntary Recall for Cardiac Marker

  •  


    The Emmes Group is a strategic business development, assessment and planning organization specializing in the support of firms engaged in the technology, internet, biotechnology and pharmaceutical industries. Our partners have over 50 years of combined experience in serving technology, internet and healthcare companies. For more information, click here.